Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
IMM01-STEM
BIOLOGICAL
3 trials
Sponsors
Immunis, Inc.
Conditions
Muscle Atrophy
Muscle Performance
Obesity and Obesity-related Medical Conditions
Sarcopenia
Sarcopenic Obesity
Phase 1
Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.
Completed
NCT05211986
Immunis, Inc.
Muscle Atrophy
Start: 2022-09-13
End: 2026-07-27
Updated: 2026-09-09
Phase 2
Safety and Efficacy of IMM01-STEM Against Placebo on Muscle Performance in Seniors With Obesity and Muscle Weakness
Active, not recruiting
NCT06600581
Immunis, Inc.
Muscle Performance, Sarcopenic Obesity
Start: 2024-12-19
End: 2026-12-15
Target: 55
Updated: 2026-01-29
Unknown Phase
INTERMEDIATE-SIZE PATIENT POPULATIONS EXPANDED ACCESS TO TREATMENT FOR SARCOPENIC OBESITY
NCT06784297
Immunis, Inc.
Obesity and Obesity-related Medical Conditions, Sarcopenia
Updated: 2026-03-06